Life sciences news
-
UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review
Friday January 6th 2023
Read more
-
Galapagos announces changes to Executive Committee
Thursday December 22nd 2022
Read more
-
University of Zagreb School of Medicine (UZSM) explains how they moved from conventional microscope histology teaching to online digital teaching with the Pathomation solutions
Thursday December 22nd 2022
Read more
-
Richter and Mithra sign binding Heads of Terms for commercialization of Donesta®
Tuesday December 20th 2022
Read more
-
Scientists discover a new brake on cell death
Tuesday December 20th 2022
Read more
-
FOx BIOSYSTEMS receives € 2.5 million EIC grant to accelerate the market introduction of unique EV analysis and isolation application
Monday December 19th 2022
Read more
-
FINTEPLA®▼ (fenfluramine) oral solution recommended for approval in the EU for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS)
Monday December 19th 2022
Read more
-
Oxurion announces the continuation of KALAHARI Phase 2, Part B Study in diabetic macular edema following interim analysis
Friday December 16th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Beiersdorf acquires S-Biomedic and strengthens expertise in the field of acne treatment
Friday December 16th 2022
Read more
-
UCB and Praxis Precision Medicines announce epilepsy research collaboration
Tuesday December 13th 2022
Read more
-
Analis takes over Vos Instrumenten
Tuesday December 13th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
